Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Trivedi (New Delhi (Delhi), India), A. Talwar (New Delhi (Delhi), India), M. Sampath (New Delhi (Delhi), India), D. Ghosh (New Delhi (Delhi), India), R. Guleria (New Delhi (Delhi), India), G. Bade (New Delhi (Delhi), India). Copy Number Variation (CNV) in Chronic Obstructive Pulmonary Disease (COPD) with and without ongoing smoking. 2708

Member's Comments

No comment yet.

Related content which might interest you: Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Distance estimation and functional distance perception in patients with Chronic Obstructive Lung Disease (COPD). Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019 Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Development of the TANDEM intervention for Chronic Obstructive Pulmonary Disease: reporting on the pre-pilot phase Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The ALONNISOS STUDY: Cross-sectional study of the prevalence of Obstructive Sleep Apnea Syndrome (OSAS) and Chronic Obstructive Pulmonary Disease (COPD) in the general population of Alonissos. Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017